Home / Tag Archives: Type 1 diabetes (page 3)

Tag Archives: Type 1 diabetes

Could Tiny RNA Molecules Transform the Future of Diabetes Care?

Scientific illustration of microRNA molecules interacting with pancreatic beta cells, highlighting their role in diabetes research, insulin regulation, and precision medicine.

Diabetes research is moving beyond blood sugar measurements and insulin therapy into an exciting new frontier. One of the most promising areas involves microRNAs, tiny RNA molecules that quietly regulate hundreds of genes throughout the body. Although they are microscopic, their influence on insulin production, inflammation, and blood vessel health …

Read More »

Can Bi-Hormonal Systems Finally Eliminate Severe Hypoglycemia?

dual-hormone-artificial-pancreas-severe-hypoglycemia

Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …

Read More »

Why Some Young Adults Lose Diabetes Control After Leaving Pediatric Care

Young adult with type 1 diabetes transitioning from a pediatric diabetes clinic to an adult endocrinology practice, illustrating the challenges of the transition to adult diabetes care.

The transition from pediatric to adult diabetes care is one of the most challenging periods in the lives of young people with diabetes. While many adolescents successfully manage their condition with the support of pediatric diabetes teams, moving into adult healthcare often coincides with worsening blood glucose control, missed appointments, …

Read More »

The Honeymoon Phase Won’t Last Forever: Are We Doing Enough to Preserve Beta Cells?

Hourglass beside a healthy pancreas illustration with insulin syringe and glucose meter representing beta-cell preservation during the type 1 diabetes honeymoon phase.

Receiving a diagnosis of type 1 diabetes can feel overwhelming. Yet for many adults, the weeks or months that follow bring an unexpected twist. Blood glucose levels often become easier to control, insulin needs decrease, and some people wonder if their diabetes is actually improving. This temporary period is known …

Read More »

Teaching Muscles to Make Insulin: Could Gene Therapy Rewrite the Future of Type 1 Diabetes?

3D medical illustration showing skeletal muscle engineered through gene therapy to produce insulin, with DNA strands, gene delivery vectors, and glucose regulation concepts representing future treatment for type 1 diabetes.

For more than a century, insulin therapy has remained the cornerstone of treatment for type 1 diabetes. While continuous glucose monitors, insulin pumps, and automated insulin delivery systems have dramatically improved diabetes management, they still do not replace the body’s natural ability to regulate blood sugar. As a result, researchers …

Read More »

Could a Mini Pancreas Predict Which Diabetes Drug Will Work Best?

Scientist holding a patient-derived pancreatic organoid in a laboratory with a pancreas model and advanced research equipment, illustrating precision diabetes medicine.

Finding the right diabetes medication often involves trial and error. One patient may respond well to a GLP-1 receptor agonist, while another sees little benefit from the same treatment. As a result, clinicians frequently adjust medications before finding the most effective option. What if doctors could test a patient’s response …

Read More »

The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome

Patient with diabetes reviewing medications, glucose monitoring supplies, and medical bills, illustrating the treatment burden associated with long-term diabetes care.

Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …

Read More »

The Return of C-Peptide: Why This Old Biomarker Is Finding New Clinical Uses

Healthcare professional reviewing C-peptide test results with a pancreatic model, blood sample, and glucose monitoring equipment representing beta-cell function assessment in diabetes care.

For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …

Read More »

Amylin Is Making a Comeback: Why This Forgotten Hormone Is Back in the Spotlight

Medical illustration showing amylin hormone activity alongside insulin therapy, highlighting next-generation amylin-based treatments for diabetes and obesity.

For years, glucagon-like peptide-1 (GLP-1) receptor agonists have dominated conversations about diabetes and obesity treatment. However, another hormone is quietly returning to the spotlight. Amylin diabetes therapy is making a comeback as researchers develop a new generation of drugs designed to improve blood glucose control and support weight management. Amylin …

Read More »